CARA - Cara Therapeutic - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

CARA is currently covered by 7 analysts with an average price target of $10.45. This is a potential upside of $10.14 (3270.97%) from yesterday's end of day stock price of $0.31.

Cara Therapeutic's activity chart (see below) currently has 48 price targets and 55 ratings on display. The stock rating distribution of CARA is 83.33% BUY, 12.5% SELL and 4.17% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 41.62% with an average time for these price targets to be met of 283.42 days.

Highest price target for CARA is $2.5, Lowest price target is $2.5, average price target is $10.45.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 22-Jan-2024. First documented stock forecast 27-Feb-2014.

Currently out of the existing stock ratings of CARA, 20 are a BUY (83.33%), 3 are a SELL (12.5%), 1 are a HOLD (4.17%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

10 months ago
(22-Jan-2024)

0/4 (0%)

$17.55 (394.38%)

Buy

$2.5

$1.45 (138.10%)

11 months 3 days ago
(19-Dec-2023)

3/15 (20%)

$1.88 (303.23%)

493

Hold

$1

$-0.05 (-4.76%)

$12

1 years 8 days ago
(14-Nov-2023)

1/8 (12.5%)

$-0.1 (-9.09%)

8

Buy

$25

1 years 3 months 13 days ago
(09-Aug-2023)

0/2 (0%)

$18.31 (273.69%)

Sell

$3.5

$2.45 (233.33%)

$4

1 years 3 months 13 days ago
(09-Aug-2023)

3/4 (75%)

$0.48 (15.89%)

22

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is CARA (Cara Therapeutic) average time for price targets to be met?

On average it took 283.42 days on average for the stock forecasts to be realized with a an average price target met ratio 41.62

Which analyst has the current highest performing score on CARA (Cara Therapeutic) with a proven track record?

COREY DAVIS

Which analyst has the most public recommendations on CARA (Cara Therapeutic)?

Corey Davis has 5 price targets and 7 ratings on CARA

Which analyst is the currently most bullish on CARA (Cara Therapeutic)?

Chris Howerton with highest potential upside - $35.38

Which analyst is the currently most reserved on CARA (Cara Therapeutic)?

David Amsellem with lowest potential downside - -$0.05

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?